News for Roche Holding AG (RHHBY)

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

We recently published a list of 10 Best Annual Dividend Stocks To Buy Now.

We recently compiled a list of the Morgan Stanley's 15 Best European AI Stocks. In this article, we are going to take a look at where Roche Holding AG (OTC:RHHVF) stands against Morgan Stanley's other...

The following slide deck was published by Roche Holding AG in conjunction with their 2024 Q4 earnings call.

Roche Holding AG (OTCQX:RHHBY) Q4 2024 Earnings Conference Call January 30, 2025 8:00 AM ETCompany ParticipantsThomas Schinecker - CEOAlan Hippe - Chief...

Medical marijuana reduces benzodiazepine prescriptions, saving patients from potential risks. This threatens big pharma's profits.

Insights into the Fourth Quarter 2024 N-PORT Filing Tweedy Browne International Value (Trades, Portfolio) recently submitted its N-PORT filing for the fourth q

Doctors may change how they treat liver cancer after drugs from AstraZeneca Plc and Merck & Co. helped some patients, marking the first treatment progress for them in decades.

Biotech giant Regeneron Pharmaceuticals (NASDAQ: REGN) started 2024 on a strong note and performed well through the first half of the year. Regeneron's stock could soar by 50% in the next year from its current levels if we go by its average price target of $1,053 (according to Yahoo! Should investors rush to buy Regeneron's shares?

Recursion Pharmaceuticals (NASDAQ: RXRX) could be one of them. Let's figure out whether investing in Recursion Pharmaceuticals ahead of 2025 is worth it. Recursion Pharmaceuticals uses AI to speed up the drug discovery and development process.

**media[487630]**

The billionaire recently bought an obesity drug stock that could soar nearly 20% over the next 12 months, according to Wall Street. Englander loaded up on Eli Lilly (NYSE: LLY) stock in Q3. Lilly ranked as the seventh-largest-holding in Millennium Management's portfolio at the end of Q3 with a valuation of over $877 million.

Global equities rose in Q3 2024, as measured by the MSCI World Index in US dollar terms. Click here to read the full commentary.

Global equities rose in the third quarter of 2024, as measured by the MSCI World Index in US dollar terms.

Clarivate Reveals Highly Cited Researchers 2024 List

Revenue at European companies failed to recover in the third quarter, triggering cuts to earnings expectations into next year.

Health stocks tumbled as vaccine sceptic RFK Jr. was named by President-elect Trump to head the Department of Health and Human Services.

Roche Holding AG is extremely optimistic that its latest experimental Alzheimer’s drug will deliver a benefit for patients, Chief Executive Officer Thomas Schinecker said, despite a track record of failures in the field.  Roche’s newest experimental Alzheimer’s drug, dubbed brain shuttle because of its technology for slipping past the protective…

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Acute Respiratory...